A phase II study of gemcitabine and immunotherapy in renal cancer: preliminary results and review of the literature

Ann Oncol. 2006 May:17 Suppl 5:v133-6. doi: 10.1093/annonc/mdj968.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Review

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Renal Cell / pathology
  • Carcinoma, Renal Cell / therapy*
  • Combined Modality Therapy
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives*
  • Female
  • Gemcitabine
  • Humans
  • Immunotherapy*
  • Interferon-alpha / administration & dosage
  • Interleukin-2 / administration & dosage
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / therapy*
  • Male
  • Middle Aged
  • Topotecan / administration & dosage

Substances

  • Interferon-alpha
  • Interleukin-2
  • Deoxycytidine
  • Topotecan
  • Gemcitabine